EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Updates on Therapeutic Strategies in the Treatment of Relapsed/Refractory Multiple Myeloma

Deevyashali S Parekh, Yun Kyoung Ryu Tiger, Kevin Tony Jamouss iD, Justin Hassani, Maroun Bou Zerdan, Shahzad Raza iD

Cancers · 23.08.2024 · 16 (17) · 2931

DOI: 10.3390/cancers16172931 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.08.2024. Verfasst von Deevyashali S Parekh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma is a heterogeneous condition characterized by the proliferation of monoclonal B-cells, for which there is currently no curative treatment available. Relapses are, unfortunately, common after first-line treatment. While the prognosis for relapsed refractory multiple myeloma is generally poor, advances in the treatment of relapsed or refractory multiple myeloma offer hope. However, the expansion of effective options in targeted treatment offers renewed optimism and hope that patients who fail on older therapies may respond to newer modalities, which are often used in combination. We review currently approved and novel investigational agents classified by mechanisms of action, efficacy, approved setting, and adverse events. We delve into future directions of treatment for relapsed/refractory multiple myeloma, reviewing novel agents and therapeutic targets for the future.

Schlagwörter

Stichwörter der Autor:innen

CAR-Tbispecific antibodiescelmodsmonoclonal antibodiesmultiple myelomaproteasome inhibitorsrelapsed refractory

Autor:innen und Institutionen

  • Department of Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
  • Rutgers Cancer Institute, New Brunswick, NJ 08901, USA.
  • University of Massachusetts Chan Medical School, Baystate Campus, Springfield, MA 01107, USA.
  • Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH 44195, USA.

ORCID-Profile: Kevin Tony Jamouss, Shahzad Raza

Zitieren

APA

Parekh, D. S., Tiger, Y. K. R., Jamouss, K. T., Hassani, J., Bou Zerdan, M., & Raza, S. (2024). Updates on Therapeutic Strategies in the Treatment of Relapsed/Refractory Multiple Myeloma. Cancers, 16(17), 2931. https://doi.org/10.3390/cancers16172931

Vancouver

Parekh DS, Tiger YKR, Jamouss KT, Hassani J, Bou Zerdan M, Raza S. Updates on Therapeutic Strategies in the Treatment of Relapsed/Refractory Multiple Myeloma. Cancers. 2024;16(17):2931. doi:10.3390/cancers16172931

BibTeX
@article{Parekh2024,
  author = {Parekh, Deevyashali S and Tiger, Yun Kyoung Ryu and Jamouss, Kevin Tony and Hassani, Justin and Bou Zerdan, Maroun and Raza, Shahzad},
  title = {Updates on Therapeutic Strategies in the Treatment of Relapsed/Refractory Multiple Myeloma},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {17},
  pages = {2931},
  doi = {10.3390/cancers16172931}
}
Kostenlos starten →